OptiMetaboliX Vanilla Delight

Suggested/Recommended/Usage/Directions

DIRECTIONS: Blend, shake, or briskly stir two level scoops (50 g) into 8-10 oz chilled water and consume one to two times daily; or take one to two scoops approximately 20-30 minutes before each main meal (upper limit of six scoops/day); or use as directed by your healthcare practitioner.

Brand IP Statement(s) re: (c), (TM), (SM)

OptiMetaboliX(TM) is an exclusive combination of well-researched, clinically validated, and highly bioavailable ingredients that provides multimodal support for healthy insulin and glucose metabolism and related pathways. It features InSea2(R) - an optimized blend of purified polyphenols from wild-crafted brown seaweed. InSea2(R) uniquely slows carbohydrate digestion and assimilation and can reduce the impact of high-glycemic foods.

General Statements: All Other Content

This newly developed, next generation dual carb controller is 100% natural, has an excellent safety profile, and is friendly to the gastrointestinal tract.

Brand IP Statement(s) re: (c), (TM), (SM)

OptiMetaboliX also delivers other innovative ingredients, including VegaPro(TM) - a proprietary sugar-free, sweetener-free, low-allergy-potential source of vegetable protein from pea protein isolate and rice protein concentrate - and CinSulin(R), a patented water extract of cinnamon with a potent 10:1 yield ratio.

General Statements: All Other Content

Cinnamon has been studied extensively for its roles in supporting healthy glucose uptake, glycogen synthesis, and insulin actin, along with maintaining blood lipids already within the normal range.

Brand IP Statement(s) re: (c), (TM), (SM)

These principal ingredients are complemented by the inclusion of thiamin (as benfotiamine) to boost transketolase activity; alpha-lipoic acid; green tea leaf extract; vanadium, chromium, and zinc as Albion(R) TRAACS(R) chelates; 5-MTHF (bioactive folate) as Quatrefolic(R); fiber from inulin; and other key vitamins and minerals.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage

STORAGE: Keep closed in a cool, dry place out of reach of children.

Precautions re: Children

STORAGE: Keep closed in a cool, dry place out of reach of children.

Formulation re: Does NOT Contain

DOES NOT CONTAIN: Wheat, gluten, yeast, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or preservatives.

General Statements: All Other Content

EXCLUSIVE PROFESSIONAL FORMULAS

General Statements: All Other Content

For Support of Healthy Glusose and Insulin Metabolism

Brand IP Statement(s) re: (c), (TM), (SM)

Featuring InSea2(R) - Next Generation Carbohydrate Control

FDA Statement of Identity

DIETARY SUPPLEMENT

General Statements: All Other Content

Pharmaceutical Grade Professional Use Only

Seals/Symbols

100% VEGAN V VegaPro(TM) 100% Gluten Free

Formula re: Contains

21g PROTEIN

Seals/Symbols

Quatrefolic(R)

Brand IP Statement(s) re: (c), (TM), (SM)

All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.

Brand IP Statement(s) re: (c), (TM), (SM)

InSea2(R) is a registered trademark of innoVactiv Inc.

Brand IP Statement(s) re: (c), (TM), (SM)

Albion(R) and TRAACS(R) are registered trademarks of Albion Laboratories, Inc. Chelates covered by US patent 7,838,042 and patents pending.

Brand IP Statement(s) re: (c), (TM), (SM)

CinSulin(R) is a registered trademark of Tang-An Medical Ltd., manufactured under US patent 6,200,569.

Seals/Symbols

AMINOGEN(R)

Brand IP Statement(s) re: (c), (TM), (SM)

AMINOGEN(R) is a registered trademark of Triarco Industries. AMINOGEN(R) is protected under U.S. patent 5,387,422.

General: Product/Version Code

ZLB-GLYVAN-03 REV. 101613

Brand IP Statement(s) re: (c), (TM), (SM)

(C) 2013 XYMOGEN

General Statements: All Other Content

This package is completely recyclable {recycle}

Precautions re: All Other

Consult your healthcare practitioner prior to use.

Precautions re: Pregnant or Nursing or Prescription Medications

Not intended for use by pregnant or lactating women or children under 12. Patients taking blood-glucose lowering medication should be monitored for hypoglycemia.

Precautions re: Children

Not intended for use by pregnant or lactating women or children under 12.

Precautions re: All Other

Do not use if tamper seal is damaged.